000			02097 a2200661 4500
005			20250513221418.0
264		0	_c20001006
008			200010s 0 0 eng d
022			_a0003-9926
024	7		_a10.1001/archinte.160.17.2659 _2doi
040			_aNLM _beng _cNLM
100	1		_aAbbas, J
245	0	0	_aCandida krusei fungemia. An escalating serious infection in immunocompromised patients. _h[electronic resource]
260			_bArchives of internal medicine _cSep 2000
300			_a2659-64 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdolescent
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAmphotericin B _xtherapeutic use
650	0	4	_aAntifungal Agents _xtherapeutic use
650	0	4	_aAntineoplastic Agents _xadverse effects
650	0	4	_aCandida albicans _xdrug effects
650	0	4	_aCase-Control Studies
650	0	4	_aCatheterization, Central Venous _xadverse effects
650	0	4	_aCatheters, Indwelling _xadverse effects
650	0	4	_aChild
650	0	4	_aChild, Preschool
650	0	4	_aDrug Resistance, Microbial
650	0	4	_aFemale
650	0	4	_aFluconazole _xtherapeutic use
650	0	4	_aFungemia _xdrug therapy
650	0	4	_aHematologic Neoplasms _xtherapy
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aImmunosuppressive Agents _xadverse effects
650	0	4	_aInfant
650	0	4	_aLogistic Models
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNeutropenia _xetiology
650	0	4	_aPrognosis
650	0	4	_aRetrospective Studies
650	0	4	_aRisk Factors
650	0	4	_aShock, Septic _xetiology
650	0	4	_aTreatment Outcome
700	1		_aBodey, G P
700	1		_aHanna, H A
700	1		_aMardani, M
700	1		_aGirgawy, E
700	1		_aAbi-Said, D
700	1		_aWhimbey, E
700	1		_aHachem, R
700	1		_aRaad, I
773	0		_tArchives of internal medicine _gvol. 160 _gno. 17 _gp. 2659-64
856	4	0	_uhttps://doi.org/10.1001/archinte.160.17.2659 _zAvailable from publisher's website
999			_c10946182 _d10946182